Landing Co., Ltd.

Wuhan Landing Intelligent Medical Co., Ltd. was founded in 2000, with its headquarters and R&D base located in the Medical Device Park of BioLake Wuhan, Optics Valley of China, with a registered capital of 24 million yuan. It is a platform company co-founded by overseas returnee Dr. Sun Xiaorong and her team, with AI big data cloud diagnosis as its technological core. Landing's main business is to use intelligent, automated, data-driven, and standardized cytopathology diagnostic technology to serve the early diagnosis of various high-incidence tumors in clinical practice.
As a national high-tech enterprise, Landing has always adhered to being market-oriented and innovation-supported. Through cross-domain and interdisciplinary resource integration, it successfully completed the independent R&D and industrialization of the AI cervical cancer cell diagnosis robot "Landing". Through cooperation with Alibaba Cloud, it established a big data diagnostic cloud platform for cervical cancer screening, pioneering a new era of intelligent cytopathology cloud diagnosis, and creating a cloud diagnostic platform for expert sharing, data sharing, and resource sharing in large-scale cervical cancer screening worldwide.
Landing's innovative AI cervical cancer screening technology has passed certifications including China FDA, U.S. FDA, and EU CE, obtained multiple national patents, and has been applied multiple times in government large-scale screening projects, highlighting the service advantages of objectivity, precision, convenience, and low cost. This technology has greatly reduced hospital diagnostic costs, improved screening efficiency, alleviated the shortage of cytopathologists at the grassroots level, broken through restrictions of geography, time, and application scenarios, truly achieving rapid, precise, and effective intelligent screening, and has received widespread attention and recognition from all sectors of society.
Landing's cloud computing platform and its nationwide third-party AI laboratory services for early cervical cancer screening will contribute to sinking medical resources in China and supporting the development of China's medical industry and services.


Benefits:
1. Five-day workweek with 7.5 working hours per day, and a competitive salary structure in the industry;
2. Statutory benefits such as five social insurances and one housing fund, paid leave, seniority pay, and year-end bonuses;
3. Transportation and living: the company provides accommodation and lunch subsidies;
4. Training opportunities: comprehensive training mechanisms and overseas study opportunities;
5. Recognition and awards: Outstanding Employee Award, Reasonable Suggestion Award, Outstanding Talent Referral Award;
6. Team benefits: monthly birthday parties, annual travel, and irregular cultural and entertainment activities, etc.